We are a clinical-stage biotechnology company developing treatments for inflammatory diseases,with an initial focus on severe respiratory disorders. Our principal corporate office is located at 890 Winter Street, Suite 200, Waltham, MA 02451. We have one subsidiary, Upstream Bio Securities Corporation, formed in November 2021 under the laws of the Commonwealth of Massachusetts.
